HD, a Thailand-based healthcare and surgery marketplace, has on Thursday announced the close of a Series A-1 strategic extension round with participation from the United States-based healthcare firm Merck Sharp & Dohme (MSD), bringing HD’s total Series A funding to $7.8 million. HD said in a statement that with additional support from from MSD, HD is poised to expand its impact even further, making affordable, accessible healthcare a reality across Southeast Asia. By 2025, the...

Life Science Incubator (LSI) has officially launched the largest co-working laboratory in Singapore at Elementum, located in JTC’s one-north business park. This launch further strengthens Singapore’s prominence as a premier life sciences hub in Asia Pacific, LSI said in a statement on Monday. As Singapore continues to be a preferred destination for biotech, MedTech, and pharmaceutical innovation, LSI opined that the demand for high-quality laboratory space remains high. It said...

Innovation in the healthcare industry is not a choice but a need to generate cost-effective solutions and better patient outcomes. The balance of data analytics and business intelligence with due diligence spurs potential areas of discovery, optimizes regular operations, and elevates healthcare quality. Business intelligence in healthcare involves collecting and processing extensive data from diverse sources such as digital health records, medi-claim documents, history of treatments,...

As the use of Gen AI tools in the workplace continues to proliferate and starts becoming a staple much like the document software that we use every day, it follows that many end users trust it to deliver faultless answers. Unfortunately, this assumption does not hold true as recent studies have revealed that Gen AI models often provide answers that are less accurate than its confidence level suggests. This mismatch between this level of accuracy and the projected confidence of Gen AI tools...

Clinical trials are becoming increasingly complex highlighting the need for efficiency. At the same time, electronic storage and computing power have increased dramatically and there are more opportunities for data sharing across industry stakeholders as patient data awareness is increasing. With these conditions, AI is poised to make scientific decisions easier and more reliable, therefore, making new drug development more efficient. The clinical trial landscape in Asia Pacific Over the...

Following Ant Group’s acquisition of Haodf, a healthcare platform specializing in online doctor consultations, Ant Group President Cyril Han and Haodf.com Founder Hang Wang have jointly announced their plans to drive AI-powered healthcare innovations. Ant Group said in a statement on last Saturday that these efforts aim to help 280,000 doctors on the Haodf platform work more efficiently and better serve 800 million healthcare users on the Alipay super app. At Haodf.com’s annual...

Singapore-headquartered healthcare investor August Global Partners (AGP) is investing in Vietnam=based genomic testing company Gene Solutions (GS) through a proprietary funding round. Gene Solutions said in a statement that the duo have signed a memorandum of understanding (MoU) for the partnership. Under the MoU, GS will support broader adoption of precision medicine and targeted therapeutics in Asia through the development of a suite of artificial intelligence (AI) technologies that...